Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO

3.950
-0.285-6.73%
Volume:16.73M
Turnover:67.18M
Market Cap:7.13B
PE:26.52
High:4.255
Open:4.290
Low:3.930
Close:4.235
52wk High:10.500
52wk Low:3.550
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:1.50
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.149
ROE:24.24%
ROA:-0.07%
PB:4.32
PE(LYR):26.52
PS:6.16

Loading ...

LEPU BIO-B (02157) Appoints Fan Xinyu as Supervisory Board Member

Stock News
·
May 19

TOT BIOPHARM publishes 2025 annual report

Reuters
·
Apr 28

Lepu Bio-B Proposes Appointment of Fan Xinyu as Supervisor

Stock News
·
Apr 27

LEPU BIO-B Releases 2025 Board Package, Maintains Zero Dividend and Seeks 20% Share Issuance Mandate

Bulletin Express
·
Apr 27

Lepu Biopharma announces annual shareholder meeting

Reuters
·
Apr 27

乐普生物2025年营收显著增长并成功扭亏为盈

Bulletin Express
·
Apr 22

Lepu Biopharma publishes 2025 annual report

Reuters
·
Apr 22

Assessing Lepu Biopharma’s Valuation After Earnings Turnaround And Share Price Surge

Simply Wall St.
·
Apr 06

LEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes

Bulletin Express
·
Apr 02

Assessing Lepu Biopharma (SEHK:2157) Valuation After Its Earnings Turnaround And Recent Share Price Strength

Simply Wall St.
·
Mar 28

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

Lepu Biopharma (SEHK:2157) Profit Swing To C¥41.7m Tests Bearish Earnings Narratives

Simply Wall St.
·
Mar 26

Stock Track | LEPU BIO-B Soars 14.84% Intraday on Strong Annual Results Showing Revenue Surge and Profit Turnaround

Stock Track
·
Mar 26

Robust Earnings Fuel Continued Gains for Hong Kong Stock Connect Biotech ETFs Amid Market Downturn

Deep News
·
Mar 26

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress
·
Mar 26

LEPU BIO-B Reports Annual Profit Turnaround with Key Drug Candidates Advancing

Stock News
·
Mar 25

Lepu Biopharma FY2025 profit attributable to owners climbs to RMB261 million; revenue rises to RMB935 million

Reuters
·
Mar 25

Lepu Biopharma FY2025; EGFR-targeting ADC Meyiuheng gains China approval for R/M NPC; revenue jumps to CNY 935 million

Reuters
·
Mar 25

Lepu Biopharma Co Ltd - Profit Attributable RMB261.4 Mln for Year

THOMSON REUTERS
·
Mar 25

Assessing Lepu Biopharma (SEHK:2157) Valuation After New 2025 Profit Guidance And Dividend Discussion

Simply Wall St.
·
Mar 15